Inhibition of Wnt/β-catenin signaling suppresses bleomycin-induced pulmonary fibrosis by attenuating the expression of TGF-β1 and FGF-2

Medicine and Dentistry

• Alveolar Epithelium 20%
• Bleomycin 80%
• Bleomycin-Induced Pulmonary Fibrosis 100%
• Catenin 100%
• Cytokine 20%
• Extracellular Matrix 20%
• Fibrinogen 100%
• Fibroblast 40%
• Fibroblast Growth Factor 2 100%
• In Vitro 40%
• Mesenchymal Stem Cell 40%
• Pulmonary Fibrosis 20%
• Silo-Filler's Disease 20%
• Transforming Growth Factor 100%
• Type 2 Epithelial Cell 20%
• Vimentin 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Bleomycin 80%
• Bleomycin-Induced Pulmonary Fibrosis 100%
• Catenin 100%
• Cytokine 20%
• Fibrinogen 100%
• Fibroblast Growth Factor 2 100%
• Lung Disease 20%
• Lung Fibrosis 20%
• Transforming Growth Factor 100%
• Vimentin 20%

Keyphrases

• Aberrant Expression 20%
• Alveolar Epithelial Type II Cells 20%
• Alveolar Epithelium 20%
• Bleomycin 80%
• Catenin 100%
• Decreased Expression 20%
• Extracellular Matrix Deposition 20%
• Fibroblast Growth factor-2 (FGF-2) 100%
• Fibroblasts 20%
• Lung Injury 20%
• Lung Tissue 20%
• Potential Therapeutic Strategies 20%
• Pulmonary Fibrosis 20%
• Transforming Growth Factor-β 100%
• Unknown Etiology 20%
• Vimentin 20%